IL6 and COVID-19: This lipid/cholinergic mediator cross-talk was positively correlated to increased intensities of inflammatory and thrombotic markers, such as neutrophil to lymphocyte ratio, neutrophil counts, international normalized ratio, and cytokine levels (IL-1β, IL-6, and IL-8), thus contributing to COVID-19 immunopathology [41].